About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited incorporated in 1981, is an Indian pharmaceutical company that develops and manufactures a wide range of pharma products across several major therapeutic areas. The company has 13 manufacturing facilities in India. These facilities can produce various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients such as chiral molecules, iron molecules, and cytotoxic substances. Emcure has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynaecology and HIV antiviral therapeutic areas for the MAT September 2023. Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files. Emcure’s marketing and distribution network in India was supported by over 5,000 field personnel who regularly interact with healthcare providers.
